BioCentury | Jun 20, 2020
Management Tracks
Nurix bolsters leadership; plus Lynch named Xilio chairman, Edgewise, BioXCel, Catabasis, Catalyst and more
...senior director, center for external innovation, rare disease at Takeda Pharmaceutical Co. Ltd. (Tokyo:4502; NYSE:TAK). Healx Ltd....
...BioCentury Staff Nurix Therapeutics Inc. Xilio Therapeutics Inc. Edgewise Therapeutics BioXcel Therapeutics Inc. Catabasis Pharmaceuticals Inc. Catalyst BioMedica Kronos Bio Inc. Canbridge Pharmaceuticals Inc. Healx Ltd. Summit...
...BioCentury Staff Nurix Therapeutics Inc. Xilio Therapeutics Inc. Edgewise Therapeutics BioXcel Therapeutics Inc. Catabasis Pharmaceuticals Inc. Catalyst BioMedica Kronos Bio Inc. Canbridge Pharmaceuticals Inc. Healx Ltd. Summit...